The initial phase of GENIE, which stands for Genomics, Evidence, Neoplasia, Information, Exchange, involves seven founding members and two informatics partners.
The Personalized Reproductive Medicine Initiative will investigate how an individual's genetic signature and personalized metrics affect overall fertility.
The consortium, a group formed by a number of participants in Oxford Nanopore's MinIon early-access program (MAP), plans to conduct a series of projects.
The database of genotype, phenotype, and clinical data from multi-drug resistant TB cases may support improved diagnostic development and clinical decision making.
Illumina is the latest to join the consortium, which is focused on personalizing cancer care.
The effort brings together gene banks, researchers, plant breeders, and big data experts, all of whom will use genomics to unlock crop diversity.
The gene fusion assay maker is the sixth member to join the consortium, which also includes Illumina and several pharmaceutical companies.
The oncology data warehouse started by the Moffitt Cancer Center and Ohio State University Comprehensive Cancer Center now has nine members.
DNAnexus' platform will support data analysis and sharing for the third phase of the Encyclopedia of DNA Elements project.
The alliance is developing new optical DNA mapping technologies for diagnostic applications.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.